House to Examine Ouster of Health Official Who Doubted Drugs Trump Pushed

0
744
House to Examine Ouster of Health Official Who Doubted Drugs Trump Pushed

into the departure of Rick Bright, who said he was removed as the head of an agency involved in developing a coronavirus vaccine after he pressed for rigorous vetting of unproven drugs embraced by President Trump to combat the virus.

“I know that life is difficult for members to travel, but we can’t let that get in the way and I’m sure that other members would want to be a part of a hearing as well,” said Representative Anna G. Eshoo, the chairwoman of the House Energy and Commerce health subcommittee. Ms. Eshoo, a California Democrat, helped create the agency that Dr. Bright oversaw, the Biomedical Advanced Research and Development Authority.

The congresswoman spoke as Dr. Bright’s lawyers, in a statement, said that officials at the Health and Human Services Department, which BARDA is a part of, had made “demonstrably false” statements about Dr. Bright’s tenure, and that they planned to file whistle-blower complaints against the agency.

Dr. Bright was abruptly dismissed this week from his BARDA post and as the department’s deputy assistant secretary for preparedness and response, and was given a narrower job at the National Institutes of Health. In response, he issued a remarkable public statement accusing the Trump administration of putting cronyism over science, especially with two malaria drugs that the president has promoted as game changers in the treatment of the virus.

Ms. Eshoo said that among the witnesses she would like to hear from are the secretary of health and human services, Alex M. Azar II, and an assistant secretary, Dr. Robert P. Kadlec, who supervised Dr. Bright.

“I think the American people deserve to know what happened here, because all of our collective fate rested on” the development of a vaccine, she said.

The Democratic chairman of the House Energy and Commerce Committee, Representative Frank Pallone Jr. of New Jersey, formally requested that the Health and Human Services Department’s inspector general also look into Dr. Bright’s removal and transfer.

“Removing Dr. Bright in the midst of a pandemic would raise serious concerns under any circumstances, but his allegations that political considerations influenced this decision heighten those concerns and demand full accountability,” Mr. Pallone wrote.

In his statement, Dr. Bright said: “Contrary to misguided directives, I limited the broad use of chloroquine and hydroxychloroquine, promoted by the administration as a panacea, but which clearly lack scientific merit. While I am prepared to look at all options and to think ‘outside the box’ for effective treatments, I rightly resisted efforts to provide an unproven drug on demand to the American public.”

Officials at the department have disputed Dr. Bright’s account and insisted there were problems with his management style. But they have so far refused to say so on the record.

A performance review from September signed by Dr. Kadlec concluded, “Dr. Bright continues to lead change in BARDA with deftness and enthusiasm.”

And in an internal email sent on Tuesday evening, Dr. Kadlec again offered praise as he described Dr. Bright’s new role in a “Shark Tank”-style effort to develop diagnostics related to the coronavirus, a collaboration between his former agency and the National Institutes of Health.

“Rick brings extensive experience and expertise in facilitating powerful public-private partnerships that advance the health and well-being of the American people,” Dr. Kadlec wrote in the email. “Under Rick’s leadership, BARDA has made tremendous progress and with the skills and knowledge he has amassed across a long career in virology and, in particular, over the past four years as our BARDA director, I know he will drive and enable” the new effort.

Ms. Eshoo said that she had worked with Dr. Bright and that he was “a thoroughbred professional.”

“This is a terrible, swift sword that has come at science, and Dr. Bright,” she said.

BARDA is a technical agency, established after the Sept. 11 attacks, that works to counter chemical, biological, radiological and nuclear threats, as well as threats from pandemic influenza. It has flexibility to fund promising research and to team up with pharmaceutical companies to advance the development of countermeasures necessary to protect the health of the American public, with the aim of having the Food and Drug Administration approve them for inclusion in the national stockpile.

Dr. Bright, a virologist, arrived at the agency when Barack Obama was president. He ran its anti-viral program, and was then promoted to other jobs, including heading the influenza and emerging infectious disease branch and working on the response to the Zika virus, before becoming its director in 2016.

“This is the removal of somebody with a very clear scientific mind and good judgment,” said Marie-Paule Kieny, a French scientist and former official at the World Health Organization, who worked with Dr. Bright on developing vaccines for seasonal and pandemic influenza. “Rick is very reflective. He is not somebody who gets excited or screams. He looks at the evidence, he looks at the science and then he confers.”

Like many career officials who worked under Mr. Obama, he was not greeted warmly by the Trump team. Officials at the Health and Human Services Department described Dr. Bright as difficult and high maintenance, despite the favorable review he had been given by Dr. Kadlec. And people familiar with the discussions said department officials had been talking about moving him out of his role for several months.

In a statement on Wednesday night aimed at disputing Dr. Bright’s claim that he objected to the way the administration wanted to distribute chloroquines, a department spokeswoman said Dr. Bright had been the person who had put in for an emergency-use authorization with the Food and Drug Administration. A person familiar with Dr. Bright’s account said that was his compromise to get some regulations in place for how the drugs were used.

  • Updated April 11, 2020

    • When will this end?

      This is a difficult question, because a lot depends on how well the virus is contained. A better question might be: “How will we know when to reopen the country?” In an American Enterprise Institute report, Scott Gottlieb, Caitlin Rivers, Mark B. McClellan, Lauren Silvis and Crystal Watson staked out four goal posts for recovery: Hospitals in the state must be able to safely treat all patients requiring hospitalization, without resorting to crisis standards of care; the state needs to be able to at least test everyone who has symptoms; the state is able to conduct monitoring of confirmed cases and contacts; and there must be a sustained reduction in cases for at least 14 days.

    • How can I help?

      The Times Neediest Cases Fund has started a special campaign to help those who have been affected, which accepts donations here. Charity Navigator, which evaluates charities using a numbers-based system, has a running list of nonprofits working in communities affected by the outbreak. You can give blood through the American Red Cross, and World Central Kitchen has stepped in to distribute meals in major cities. More than 30,000 coronavirus-related GoFundMe fund-raisers have started in the past few weeks. (The sheer number of fund-raisers means more of them are likely to fail to meet their goal, though.)

    • What should I do if I feel sick?

      If you’ve been exposed to the coronavirus or think you have, and have a fever or symptoms like a cough or difficulty breathing, call a doctor. They should give you advice on whether you should be tested, how to get tested, and how to seek medical treatment without potentially infecting or exposing others.

    • Should I wear a mask?

      The C.D.C. has recommended that all Americans wear cloth masks if they go out in public. This is a shift in federal guidance reflecting new concerns that the coronavirus is being spread by infected people who have no symptoms. Until now, the C.D.C., like the W.H.O., has advised that ordinary people don’t need to wear masks unless they are sick and coughing. Part of the reason was to preserve medical-grade masks for health care workers who desperately need them at a time when they are in continuously short supply. Masks don’t replace hand washing and social distancing.

    • How do I get tested?

      If you’re sick and you think you’ve been exposed to the new coronavirus, the C.D.C. recommends that you call your healthcare provider and explain your symptoms and fears. They will decide if you need to be tested. Keep in mind that there’s a chance — because of a lack of testing kits or because you’re asymptomatic, for instance — you won’t be able to get tested.

    • How does coronavirus spread?

      It seems to spread very easily from person to person, especially in homes, hospitals and other confined spaces. The pathogen can be carried on tiny respiratory droplets that fall as they are coughed or sneezed out. It may also be transmitted when we touch a contaminated surface and then touch our face.

    • Is there a vaccine yet?

      No. Clinical trials are underway in the United States, China and Europe. But American officials and pharmaceutical executives have said that a vaccine remains at least 12 to 18 months away.

    • What makes this outbreak so different?

      Unlike the flu, there is no known treatment or vaccine, and little is known about this particular virus so far. It seems to be more lethal than the flu, but the numbers are still uncertain. And it hits the elderly and those with underlying conditions — not just those with respiratory diseases — particularly hard.

    • What if somebody in my family gets sick?

      If the family member doesn’t need hospitalization and can be cared for at home, you should help him or her with basic needs and monitor the symptoms, while also keeping as much distance as possible, according to guidelines issued by the C.D.C. If there’s space, the sick family member should stay in a separate room and use a separate bathroom. If masks are available, both the sick person and the caregiver should wear them when the caregiver enters the room. Make sure not to share any dishes or other household items and to regularly clean surfaces like counters, doorknobs, toilets and tables. Don’t forget to wash your hands frequently.

    • Should I stock up on groceries?

      Plan two weeks of meals if possible. But people should not hoard food or supplies. Despite the empty shelves, the supply chain remains strong. And remember to wipe the handle of the grocery cart with a disinfecting wipe and wash your hands as soon as you get home.

    • Can I go to the park?

      Yes, but make sure you keep six feet of distance between you and people who don’t live in your home. Even if you just hang out in a park, rather than go for a jog or a walk, getting some fresh air, and hopefully sunshine, is a good idea.

    • Should I pull my money from the markets?

      That’s not a good idea. Even if you’re retired, having a balanced portfolio of stocks and bonds so that your money keeps up with inflation, or even grows, makes sense. But retirees may want to think about having enough cash set aside for a year’s worth of living expenses and big payments needed over the next five years.

    • What should I do with my 401(k)?

      Watching your balance go up and down can be scary. You may be wondering if you should decrease your contributions — don’t! If your employer matches any part of your contributions, make sure you’re at least saving as much as you can to get that “free money.”


Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here